Khiron Life Sciences Stock Five Year Return
Khiron Life Sciences fundamentals help investors to digest information that contributes to Khiron Life's financial success or failures. It also enables traders to predict the movement of Khiron Pink Sheet. The fundamental analysis module provides a way to measure Khiron Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Khiron Life pink sheet.
Khiron |
Khiron Life Sciences Company Five Year Return Analysis
Khiron Life's Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
More About Five Year Return | All Equity Analysis
Five Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Although Five Year Returns can give a sense of overall investment potential, it is recommended to compare equity performance with similar assets for the same five year time interval. Similarly, comparing overall investment performance over the last five years with the appropriate market index is a great way to determine how this equity instrument will perform during unforeseen market fluctuations.
Competition |
According to the company disclosure, Khiron Life Sciences has a Five Year Return of 0.0%. This indicator is about the same for the Healthcare average (which is currently at 0.0) sector and about the same as Drug Manufacturers—Specialty & Generic (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Volatility Analysis Now
Volatility AnalysisGet historical volatility and risk analysis based on latest market data |
All Next | Launch Module |
Khiron Fundamentals
Return On Equity | -0.75 | |||
Return On Asset | -0.21 | |||
Profit Margin | (1.90) % | |||
Operating Margin | (1.08) % | |||
Current Valuation | 9.19 M | |||
Shares Outstanding | 216.39 M | |||
Shares Owned By Insiders | 5.00 % | |||
Shares Owned By Institutions | 0.23 % | |||
Price To Book | 0.45 X | |||
Price To Sales | 0.54 X | |||
Revenue | 12.79 M | |||
Gross Profit | 6.37 M | |||
EBITDA | (32.03 M) | |||
Net Income | (33.13 M) | |||
Cash And Equivalents | 5.82 M | |||
Cash Per Share | 0.03 X | |||
Total Debt | 705 K | |||
Debt To Equity | 0.08 % | |||
Current Ratio | 2.83 X | |||
Book Value Per Share | 0.12 X | |||
Cash Flow From Operations | (20.4 M) | |||
Earnings Per Share | (0.15) X | |||
Number Of Employees | 15 | |||
Beta | 3.05 | |||
Market Capitalization | 17.83 M | |||
Total Asset | 42.27 M | |||
Z Score | 15.0 | |||
Net Asset | 42.27 M |
About Khiron Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Khiron Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Khiron Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Khiron Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Khiron Pink Sheet
Khiron Life financial ratios help investors to determine whether Khiron Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Khiron with respect to the benefits of owning Khiron Life security.